Guardant Health
GH
$27.62
Share price
7.05%
Change (1 day)
-46.97%
Change (1 year)
Categories
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.
Earnings for Guardant Health (GH)
Earnings in 2023 (TTM): -$0.51 B
According to Guardant Health 's latest financial reports the company's current earnings (TTM) are -$0.51 B. In 2022 the company made an earning of -$0.66 B a decrease over its 2021 earnings that were of -$0.39 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Guardant Health from 2018 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.51 B | -22.45% |
| 2022 | -$0.66 B | 69.96% |
| 2021 | -$0.39 B | 56.35% |
| 2020 | -$0.25 B | 252.69% |
| 2019 | -$69.73 M | -17.22% |
| 2018 | -$84.23 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Neogen NEOG | -$22.05 M | -95.65% | 🇺🇸 USA |
 Natera NTRA | -$0.52 B | 0.89% | 🇺🇸 USA |